Bio

Bryan Jackson (Menlo Park) joined KKR in 2018 and is a member of the Health Care industry team. Mr. Jackson has been involved with the firm’s investments in AcuFocus, Falcon Vision, Slayback Pharma and Blue Sprig Pediatrics. Prior to joining KKR, Mr. Jackson was a principal at Blue Harbour Group, a public markets fund based in Greenwich, CT. He started his career at The Blackstone Group, where he was an analyst in both the private equity and restructuring advisory groups. Mr. Jackson received his B.B.A., summa cum laude, from the University of Notre Dame and his M.B.A., with distinction, from Harvard Business School.